Category: In Vitro Diagnostics
In Vitro Diagnostics market research reports by GlobalData
-
Australia IVD Analyzers Market Outlook to 2033 - Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers and Others
Australia IVD Analyzers Market Outlook to 2033 - Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers and Others Summary GlobalData’s “Australia IVD Analyzers Market Outlook to 2033” is a comprehensive databook report, covering key market data on the Australia ... Read More
-
Strategic Intelligence: China Impact on Medical Devices (2025)
Strategic Intelligence: China Impact on Medical Devices (2025) Summary China is among the top 10 largest medical device markets worldwide and is regarded as one of the most promising. The estimated market value of medical devices in China was around $61.1 billion in 2024, accounting for 10.5% of the ... Read More
-
Strategic Intelligence: Point-of-Care Diagnostics (2025)
Strategic Intelligence: Point-of-Care Diagnostics (2025) Summary Point-of-care tests (POCTs) are medical tests performed at the time and place of patient care. Point-of-care (POC) diagnostics include blood glucose testing, rapid cardiac marker testing, and infectious disease testing. POC testing dev ... Read More
-
Colorectal Cancer Screening Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036
Colorectal Cancer Screening Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 Summary Colorectal Cancer Screening Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 is built to visualize quantitative and qualitative market trends ... Read More
-
Advanced Marker Discovery SL - Product Pipeline Analysis, 2024 Update
Summary Advanced Marker Discovery SL (Amadix) is a developer and discoverer of cancer diagnostic products. The company provides test products and diagnostic tools for lung cancer, colon cancer and prostate cancer. It offers diagnostic tools that support the physician’s decisions about patient manage ... Read More
-
Hepatitis C Therapeutics: Competitive Landscape
Hepatitis C Therapeutics: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Hepatitis C Therapeutics . GlobalData epidemiologists estimate that there will be 25.16 million diagnosed prevalent cases of Hepatitis C (HCV) infec ... Read More
-
Glucose Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Glucose Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Glucose Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, ... Read More
-
Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, ... Read More
-
Therapeutic Drug Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Therapeutic Drug Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Therapeutic Drug Monitoring Pipeline Report including Stages of Development, Segments, Regi ... Read More
-
Hepatitis B Therapeutics: Competitive Landscape
Hepatitis B Therapeutics: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Hepatitis B Therapeutics . GlobalData epidemiologists estimate that there will be 21.91 million diagnosed prevalent cases of HBV in 2024, which is e ... Read More
-
Hematological Disorders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Hematological Disorders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Hematological Disorders Pipeline Report including Stages of Development, Segments, Region and C ... Read More
-
Point of Care (POC) Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Point of Care (POC) Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Point of Care (POC) Analyzers Pipeline Report including Stages of Development, Segments, ... Read More
-
Histology And Cytology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Histology And Cytology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Histology And Cytology Pipeline Report including Stages of Development, Segments, Region and Cou ... Read More
-
HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments ... Read More
-
Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Regi ... Read More
-
Hematology Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Hematology Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Hematology Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regu ... Read More
-
Biodesix Inc (BDSX) - Product Pipeline Analysis, 2024 Update
Summary Biodesix Inc (Biodesix) discovers, develops and commercializes testing solutions for lung Diseases. The company's services include diagnostic test and biopharma services. Its Biopharma services include biomarker discovery and development, companion diagnostic partnering and clinical trial su ... Read More
-
Flow Cytometers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Flow Cytometers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Flow Cytometers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary Glob ... Read More
-
Diabetes Assays Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Diabetes Assays Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Diabetes Assays Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary Glob ... Read More
-
Point of Care (POC) Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Point of Care (POC) Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 Summary Point of Care (POC) Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative and qua ... Read More
-
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 Summary Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative and qualitative ... Read More
-
Hepatitis C Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Hepatitis C Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 Summary Hepatitis C Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics the ... Read More
-
Bone Metabolism Assays Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Bone Metabolism Assays Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Bone Metabolism Assays Pipeline Report including Stages of Development, Segments, Region and Cou ... Read More
-
Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 Summary Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics the ... Read More
-
ALK Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
ALK Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 Summary ALK Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area. A ... Read More
Research Assistance
